Delivery Order SPE2DR25D2104-SPE2DR26F3TBF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for $11,316.77 to supply Triumeq 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency awarded a $85,522.33 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This contract, valued at $39,484.25, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $6,519.84 for TRIUMEQ 600-50-300 mg tablets in quantities of 30, with a firm fixed price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,346.58 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets in 30-unit packages. The contract is a non-set-aside, firm fixed price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,290.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of December 17, 2025. This competitively awarded contract, which carries no set-aside designation, supports federal pharmaceutical procurement needs with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563203250 TRIUMEQ 600-50-300 MG TABLET UU 30S. The $14,326.94 award has a completion date of January 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order, which does not have a set-aside designation. As a pharmaceutical distributor, Amerisourcebergen has previously...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 30-count supplies of TRIUMEQ 600-50-300 mg tablets with a ceiling value of $55,079.80 under firm fixed-price terms. The award, which carries an ultimate completion date of August 13, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $35,718.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET 30S, a pharmaceutical product, with a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TBFDelivery Order
On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,406.24 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contracting portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. As a non-set-aside awardee competing on a full and open basis, AmerisourceBergen has consistently demonstrated the capability to efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/6/26 |